Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Location: United States
Total raised: $136.5M
Investors 1
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 07.11.2025 | - | $40M | Venture In... |
| 23.01.2024 | Series C | $55M | - |
| 09.09.2022 | Series B | $41.5M | - |
Mentions in press and media 10
| Date | Title | Description |
| 07.11.2025 | Elephas Biosciences: $40 Million Series B-2 Raised To Advance Commercialization Of Live Tumor Profiling Platform | Elephas Biosciences has secured $40 million in Series B-2 financing to support the launch and commercialization of its Elephas Live Platform, a laboratory-developed test expected to be introduced in 2026. The company, based in Madison, Wisc... |
| 06.11.2025 | Elephas Biosciences Raises $40M in Series B-2 Funding | Elephas Biosciences, a Madison, WI-based private company that has developed a live tumor profiling platform for immunotherapy response prediction, raised $40M in Series B-2 funding. Backers included Northpond Ventures, ARCH Venture Partners... |
| 23.01.2024 | Elephas Raises $55M in Series C Funding | Elephas, a Madison, WI-based company developing an ex-vivo platform to assess how live patient biopsies respond to immunotherapies, raised $55M in Series C funding. The round, which brought the total amount to $116.5M, was led by Venture In... |
| 23.01.2024 | Elephas Biosciences raises $55 million led by Madison-based investors | - |
| 23.01.2024 | Elephas Biosciences Lands $55M Series C | MADISON, WI, Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $55 million in Series C funding. >> Click here for more funding data on Elephas Biosciences >> To export Elephas B... |
| 07.09.2022 | Elephas Biosciences Raises $41.5M in Series B Funding | Elephas Biosciences Corporation, a Madison, Wis.-based oncology diagnostics company, raised $41.5m in Series B funding. The round was led by ARCH Venture Partners, joined by new investors, Moore Strategic Ventures and Tao Capital Partners, ... |
| 06.09.2022 | Elephas Biosciences Secures $41.5M Series B | MADISON, WI, Elephas Biosciences announced today that it has raised $41.5 million in Series B funding. >> Click here for more funding data on Elephas Biosciences >> To export Elephas Biosciences funding data to PDF and Excel... |
| - | Elephas | “Home | Elephas | Elephas Platform” |
| - | Elephas Biosciences: Oncology Imaging Diagnostics Platform Company Raises $55 Million | Elephas Biosciences announced today that it has raised $55 million in Series C funding. Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB) led the round. Existing investors that joined the round include Northpond V... |
| - | Manage your consent preferences Elephas Biosciences raises $55 million led by Madison-based investors | - |